mRNA vaccine technology has helped repair broken hearts in mice

By Michael Le Page

mRNA

An illustration of a strand of mRNA

MattLphotography / Alamy Stock Photo

Immune cells in the bodies of mice have been temporarily reprogrammed to repair damaged hearts by removing scar tissue, thanks to the technology used in the mRNA coronavirus vaccines.

“After you give the treatment, the scar goes away,” says Haig Aghajanian at the University of Pennsylvania.

Genetically engineered immune cells called CAR T-cells are already being used to treat cancer, but this is extremely expensive. The mRNA approach, which involves only temporarily modifying these cells, could dramatically decrease costs.

“CAR-T therapy has been a breakthrough, but it costs a lot,” says Aghajanian. “We’re hoping this is the next step in CAR-T-type technology that will allow more access. This type of thing you can get to developing countries, to remote areas.”

T-cells are immune cells that use receptors on their surface to recognise cells infected with viruses, which they then destroy. T-cells can be reprogrammed to target any desired cell type by giving them the appropriate receptor.

Conventional CAR T-cells are made by taking T-cells from a person’s body, genetically engineering them to add a gene for a “chimeric antigen receptor” – hence the name – and then returning them to that individual’s body. Such treatments can be very effective against cancers of the blood such as leukaemia, but producing the cells in a laboratory isn’t cheap. The first CAR-T treatment to get approved, called Kymriah, cost $475,000.

Aghajanian’s team is instead turning T-cells into CAR T-cells without removing them from the body, by delivering genes in the form of mRNAs. The mRNAs are packaged inside the same fatty balls, called lipid nanoparticles, as is used in the Pfizer/BioNTech and Moderna coronavirus vaccines.

In this case, however, the lipid nanoparticles have antibodies attached to them that bind to T-cells. The team had already been working on their research before the vaccines, but Aghajanian says the mass roll-out of vaccines should make it easier to get other uses of lipid nanoparticles approved by regulators

Some other teams have tried by create CAR T-cells inside the body by using viruses to permanently add DNA genes to the genomes of T-cells. This is potentially risky if something goes wrong.

mRNAs, by contrast, are temporary copies of genes used as templates by protein-making factories. They are not integrated into the genome and only persist for days. This means that adding mRNAs to T-cells doesn’t permanently alter them. In other words, it is a way of creating transient CAR T-cells. “It does its thing for a few days and then it is gone,” says Aghajanian.

His team has used this approach to target the cells that lay down collagen, which our bodies constantly produce, while other cells remove it. What happens after an injury is that the balance changes, because the cells that lay down collagen overproliferate, leading to a scar.

“They start putting down scar faster than other cells can take it up,” says Aghajanian. “If you can get rid of these cells, it goes back into balance and the scar quickly recedes.”

To test the method, his team damaged the hearts of mice in a way that creates a lot of scarring, or fibrosis. This makes the tissue stiffer and impairs the contraction and relaxation of the heart. Two weeks after the infusion of mRNA nanoparticles, the amount of scar tissue in the hearts of the mice was nearly halved of that in untreated animals, and their heart function improved significantly.

Besides treating injured hearts, the same approach might work for treating fibrosis of other organs including the kidney, liver and intestine, says Aghajanian. It might also be possible to treat scars on the skin with local injections. More generally, targeted delivery of mRNA to specific cells could be used to treat all kinds of diseases.

“It’s an encouraging demonstration that T-cells can be modified in vivo,” says Waseem Qasim at the Great Ormond Street Institute of Child Health in London, whose team is carrying out trials of CAR-T therapies.

Journal reference: Science, DOI: 10.1126/science.abm0594

Sign up to our free Health Check newsletter for a round-up of all the health and fitness news you need to know, every Saturday

More on these topics:

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Most of Us Combine Personality Traits from Different Genders thumbnail

Most of Us Combine Personality Traits from Different Genders

How different are men and women really? About 30 years ago, if dating guides are any indication, some people assumed vast differences in personality, with Men Are from Mars, Women Are from Venus relationship advice. Today, by contrast, certain communities are pushing back against the idea of binary gender, which presents men and women as…
Read More
Out of This World Archaeological Experiment Lands in Space thumbnail

Out of This World Archaeological Experiment Lands in Space

A world-first – or solar system-first – archaeological project has this week begun on the International Space Station. Led by archaeologists Associate Professor Alice Gorman from Flinders University and Associate Professor Justin Walsh of Chapman University in California, the International Space Station Archaeological Project (ISSAP) is the first archaeological study of a space habitat. “We’re…
Read More
Understanding how the brain interprets other’s gazes thumbnail

Understanding how the brain interprets other’s gazes

Understanding where others are looking is crucial in everyday interactions. Our brain quickly interpret gaze direction to communicate effectively. A recent study in NeuroImage by the University of Geneva pinpointed exactly when our brains detect gaze direction. This insight is crucial for understanding conditions like autism and may help in Alzheimer’s therapy. Since birth, faces
Read More
After strikeout in negotiations, MLB scraps opening day thumbnail

After strikeout in negotiations, MLB scraps opening day

Jupiter, Fla. Major League Baseball’s financial fight cost regular-season games for the first time in 27 years when often acrimonious talks to end a management lockout collapsed Tuesday and Commissioner Rob Manfred scrapped the March 31 openers.With owners and players unable to agree on a contract to replace the collective bargaining agreement that expired Dec.…
Read More
Index Of News
Total
0
Share